Cargando…
Limitations of current in vitro models for testing the clinical potential of epigenetic inhibitors for treatment of pediatric ependymoma
BACKGROUND: Epigenetic modifications have been shown to play an important role in the classification and pathogenesis of the pediatric brain tumor ependymoma, suggesting they are a potential therapeutic target. RESULTS: Agents targeting epigenetic modifications inhibited the growth and induced the d...
Autores principales: | Rogers, Hazel Anne, Chapman, Rebecca, Kings, Holly, Allard, Julie, Barron-Hastings, Jodie, Pajtler, Kristian W., Sill, Martin, Pfister, Stefan, Grundy, Richard Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284855/ https://www.ncbi.nlm.nih.gov/pubmed/30559935 http://dx.doi.org/10.18632/oncotarget.26370 |
Ejemplares similares
-
Molecular dissection of ependymomas
por: Pajtler, Kristian W., et al.
Publicado: (2015) -
EPEN-28. Oncogenic dependency of pediatric ependymomas on extracellular vesicle pathways
por: Maass, Kendra K, et al.
Publicado: (2022) -
EPEN-47. PEDS: PEDIATRIC EPENDYMOMA DISCOVERY STUDY
por: Smith, Amy, et al.
Publicado: (2020) -
Pediatric ependymomas: destined to recur?
por: Ritzmann, Timothy A, et al.
Publicado: (2021) -
EPEN-42. MOLECULAR PROFILING REVEALS DISTINCT SUBGROUPS OF PEDIATRIC SPINAL EPENDYMOMA
por: Ahmad, Omar, et al.
Publicado: (2020)